Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Recent evidence suggests that many malignancies, including breast cancer, are driven by a cellular subcomponent that displays stem cell-like properties. The protein phosphatase and tensin homolog (PTEN) is inactivated in a wide range of human cancers, an alteration that is associated with a poor prognosis. Because PTEN has been reported to play a role in the maintenance of embryonic and tissue-specific stem cells, we investigated the role of the PTEN/Akt pathway in the regulation of normal and malignant mammary stem/progenitor cell populations. We demonstrate that activation of this pathway, via PTEN knockdown, enriches for normal and malignant human mammary stem/progenitor cells in vitro and in vivo. Knockdown of PTEN in normal human mammary epithelial cells enriches for the stem/progenitor cell compartment, generating atypical hyperplastic lesions in humanized NOD/SCID mice. Akt-driven stem/progenitor cell enrichment is mediated by activation of the Wnt/beta-catenin pathway through the phosphorylation of GSK3-beta. In contrast to chemotherapy, the Akt inhibitor perifosine is able to target the tumorigenic cell population in breast tumor xenografts. These studies demonstrate an important role for the PTEN/PI3-K/Akt/beta-catenin pathway in the regulation of normal and malignant stem/progenitor cell populations and suggest that agents that inhibit this pathway are able to effectively target tumorigenic breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Knockdown of PTEN in normal mammary epithelial cells implanted into humanized mouse fat pads resulted in disorganized, hyperplastic lesions (44).”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [44]
In the citing paper
“These outgrowths displayed increased basal markers (smooth muscle actin, CK5, CK6) and decreased luminal markers (estrogen receptor, CK18), similar to our findings with mislocalization of SCRIB.”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012 · cited 8×
“Mammary tissue from reduction mammoplasties was dissociated as previously described [19].”
BackgroundMethodInfluentialSelf-citationA collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188 · cited 1×
“screened 38 breast cancer cell lines including MCF7 for various pathways and found that MCF7 cells displayed significantly low levels of the PI3/Akt activation when compared with other cell lines [52].”
BackgroundmTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561 · cited 1×
“loop [43–46].”
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406 · cited 2×
“Mammosphere cultures were grown in a serum-free mammary epithelium basal medium as previously described [18].”
BackgroundMethodSelf-citationSato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,109 · cited 1×
“To examine the role of Wnt/b-catenin signaling, we used the GSK3-b inhibitor 6-bromoindirubin-39-oxime (Bio), which has been shown to be able to maintain pluripotency of human and mouse embryonic stem cells through activation of bcatenin signaling [30].”
MethodNagata, Y., Lan, K.-H., Zhou, X., Tan, M., Esteva, F. J., Sahin, A. A., Klos, K. S., Li, P., Monia, B. P., Nguyen, N. T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.022 · Cited by 1,858 · cited 2×
“therapeutic agents and relapse following initial treatment [7,8].”
BackgroundInfluentialIntrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794 · cited 1×
“Recent evidence utilizing in vitro systems [56], animal models [13], and clinical trials have suggested that breast cancer stem cells are relatively resistant to both radiation and chemotherapy [57].”
BackgroundBerns, K., Horlings, H. M., Hennessy, B. T., Madiredjo, M., Hijmans, E. M., Beelen, K., Linn, S. C., Gonzalez-Angulo, A. M., Stemke-Hale, K., Hauptmann, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.030 · Cited by 1,627
Purification and unique properties of mammary epithelial stem cells
Stingl, J., Eirew, P., Ricketson, I., Shackleton, M., Vaillant, F., Choi, D., Li, H. I., & Eaves, C. J. (2006) · Nature · doi:10.1038/nature04496 · Cited by 1,559 · cited 1×
“Furthermore, recent studies have shown that mammary stem cells are not contained within the SP population [47].”
BackgroundPten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516 · cited 2×
“heterozygous mice developing tumors in several organs including the breast [5,34].”
Background
Cited by
Items 501–532 of 532
Breast cancer stem cells and their role in tumor microenvironment
Mir, M. A., & Naik, A. Q. (2022) · Elsevier eBooks · doi:10.1016/b978-0-443-18696-7.00005-1
ROS and Redox Regulation/Signaling and Metabolism in Cancer Stem Cells
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_2 · Cited by 2
Shah Sandip, A., Mirza, S., S.S., P., & Rawal Rakesh, M. (2016) · Gujarat Cancer Society Research Journal · doi:10.5005/gcsrj-11042-18106
Burnett, J. (2015) · Deep Blue (University of Michigan)
Gao, W., Guo, N., Yan, H., Zhao, S., Sun, Y., & Chen, Z. (2024) · Figshare · doi:10.6084/m9.figshare.25123867
Gao, F., Liu, S., Wang, J., Wei, G., Yu, C., Zheng, L., Sun, L., Wang, G., Sun, Y., Bao, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26339886
Bouamar, H., Broome, L. E., Lathrop, K. I., Jatoi, I., Brenner, A. J., Nazarullah, A. N., Gorena, K. M., Garcia, M., Chen, Y., Kaklamani, V., et al. (2023) · Figshare · doi:10.6084/m9.figshare.26633859
Bouamar, H., Broome, L. E., Lathrop, K. I., Jatoi, I., Brenner, A. J., Nazarullah, A. N., Gorena, K. M., Garcia, M., Chen, Y., Kaklamani, V., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26633868
Bouamar, H., Broome, L. E., Lathrop, K. I., Jatoi, I., Brenner, A. J., Nazarullah, A. N., Gorena, K. M., Garcia, M., Chen, Y., Kaklamani, V., et al. (2023) · Figshare · doi:10.6084/m9.figshare.26633862
Bouamar, H., Broome, L. E., Lathrop, K. I., Jatoi, I., Brenner, A. J., Nazarullah, A. N., Gorena, K. M., Garcia, M., Chen, Y., Kaklamani, V., et al. (2023) · Figshare · doi:10.6084/m9.figshare.26633853
Bouamar, H., Broome, L. E., Lathrop, K. I., Jatoi, I., Brenner, A. J., Nazarullah, A. N., Gorena, K. M., Garcia, M., Chen, Y., Kaklamani, V., et al. (2023) · Figshare · doi:10.6084/m9.figshare.26633856
Bouamar, H., Broome, L. E., Lathrop, K. I., Jatoi, I., Brenner, A. J., Nazarullah, A. N., Gorena, K. M., Garcia, M., Chen, Y., Kaklamani, V., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26633865
Bouamar, H., Broome, L. E., Lathrop, K. I., Jatoi, I., Brenner, A. J., Nazarullah, A. N., Gorena, K. M., Garcia, M., Chen, Y., Kaklamani, V., et al. (2023) · Figshare · doi:10.6084/m9.figshare.26633850
Repositionnement d'un inhibiteur de métalloprotéases dans le cancer du sein
M'Hidi, L. M. (2013) · theses.fr (ABES) · doi:10.70675/60108424z3ec9z4cb2zaa9bz4385d4349805
Etude des réponses induites par l’erlotinib dans des cellules de lignées de glioblastome
Eimer, S. (2011) · theses.fr (ABES) · doi:10.70675/48cf26bbz6b1cz4672za2d5zc83a7ce5752a
Caractérisation des cellules souches cancéreuses des sous types luminaux dans le cancer du sein
Nguyen, T. T. (2013) · theses.fr (ABES) · doi:10.70675/78f35f8dz1b4ez4687z8c9eza46879878137
Ouzounova, M. (2011) · theses.fr (ABES) · doi:10.70675/88c0f728zfd49z4d5ezaca4z3418d223eb01
Etude des réactions enzymatiques par électrophorèse capillaire
Nehmé, H. (2013) · theses.fr (ABES) · doi:10.70675/c7241e6bzf6c2z4026z992az1a1d0ce52080
Etude du rôle des intégrines liant la laminine dans le développement et la tumorigenèse mammaires
Cagnet, S. (2013) · theses.fr (ABES) · doi:10.70675/bf5583e4z5b7ez48acz932dzee50fcdb3614
Salvador, M. A. (2014) · theses.fr (ABES) · doi:10.70675/e6271213z23d6z45e2z8558z016ac2e02ef3
Helou, R. E. (2015) · theses.fr (ABES) · doi:10.70675/b8b014d8z89d6z430azbcdaz904de9456f21
Rôle de l'autophagie dans l'émergence des cellules souches cancéreuses : implication du métabolisme
El-Hout, M. (2019) · theses.fr (ABES) · doi:10.70675/881cf980z01caz4a56z8a81zdcebe1247536
Rakotomalala, A. (2024) · theses.fr (ABES) · doi:10.70675/e937423cze44az4c14zbbb3z4010f3248137
LRRC32 Mediates Resistance to Everolimus in Hormone Receptor-Positive, HER2-Negative Breast Cancer
Wang, L., Chen, X., Li, X., Wang, Y., & Shen, R. (2026) · Cancer Management and Research · doi:10.2147/cmar.s619010
Karmokar, A. (2014) · Figshare · Cited by 1
Rybak, A. P. (2013) · MacSphere (McMaster University) · doi:10.71548/8413
Metadata
- Authors
- Korkaya, H., Paulson, A., Charafe-Jauffret, E., Ginestier, C., Brown, M., Dutcher, J., Clouthier, S. G., & Wicha, M. S.
- Affiliations
- University of Michigan (US)
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-06-02
- Volume
- 7
- Issue
- 6
- Pages
- e1000121
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC2683567
- OpenAlex
- W2009094422
- Cited by
- 523
- References
- 58
- Citations by year
- 2025: 8 · 2024: 11 · 2023: 16 · 2022: 21 · 2021: 21 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 23 · 2016: 39 · 2015: 59 · 2014: 42 · 2013: 65 · 2012: 64
- FWCI
- 25.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- University of Michigan
- A. Alfred Taubman Medical Research Institute
- National Institutes of Health (CA46592)
- School of Medicine, Stanford University
- National Cancer Institute (CA101860, 5P30 CA 46592, R01CA129765, CA129765, R01CA101860, P30CA046592)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- mammary stem/progenitor cells, PTEN, Akt signaling, Wnt/β-catenin signaling, breast cancer, perifosine, PI3K/Akt signaling, atypical hyperplasia, breast tumor xenografts, cancer stem cells
- MeSH terms
- Animals, Breast, Breast Neoplasms, Female, Gene Expression Regulation, Humans, Mammary Glands, Animal, Stem Cells, Neoplastic Stem Cells, Signal Transduction, Mice, SCID, Mice, Inbred NOD, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, beta Catenin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.